So what do we as Europeans think about the US tax levy on medical device sales? What’s true is that the tax is tough for an already heavily taxed US medical device industry which has shone brightly as one of the country’s success stories for as long as anyone can remember. We argue that the biggest impact will be on investor sentiment with the knock-on effect of reducing some companies’ propensity to innovate. The paradox is that continued innovation is likely to be a success determinant because the new tax is akin to a Darwinian change in the environment, following which the strongest will survive and thrive.
You can find an opinion piece from medlatest here, where our editor gets his chance to address the issue from a rather more “Yorkshire” perspective.
Source: MDDI online.
published: January 30, 2012 in: medlatest Editorial